Stonnington Group, LLC Reata Pharmaceuticals Inc Transaction History

Stonnington Group, LLC

  • $381 Million
  • Q1 2023

A detailed history of Stonnington Group, LLC transactions in Reata Pharmaceuticals Inc stock. As of the latest transaction made, Stonnington Group, LLC holds 10,100 shares of RETA stock, worth $0. This represents 0.24% of its overall portfolio holdings.

Number of Shares
10,100
Holding current value
$0
% of portfolio
0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023
BUY
$30.85 - $93.17 $311,585 - $941,017
10,100 New
10,100 $918,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email